Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2101178	注射用重组抗IgE人源化单克隆抗体	Lyophilized	Biological Products(3.3)	New Drug Application	2021-07-12		Shanghai Taiyin Biotechnology Co Ltd			view
CXSL2101079	注射用重组抗IgE人源化单克隆抗体	Lyophilized	Biological Products(3.3)	New Drug Application	2021-05-18		Shanghai Xiesheng Medical Technology Co Ltd			view
CXSL0600050	注射用重组抗IgE人源化单克隆抗体	Lyophilized	Biological Products(2)	New Drug Application	2006-12-07	上海张江生物技术有限公司	Shanghai Zhangjiang BIOTECHNOLOGY Co Ltd	Certificate Issued	2008-02-22	view
CXSL1700097	注射用重组抗IgE人源化单克隆抗体	Lyophilized	Biological Products(2)	New Drug Application	2017-10-19	海正药业（杭州）有限公司	Hisun Pharmaceutical (Hangzhou) Co Ltd	Certificate Issued	2018-10-22	view